RNAZ TransCode Therapeutics, Inc. logo

RNAZ TransCode Therapeutics, Inc.

Healthcare
$6.24+2.04%ClosedMarket Cap: $5.9M

As of 2026-05-25

Analyst Consensus

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

Rating Distribution

1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Dec 31$-8.96$500.0K1
Fri Dec 31$-6.72$9.7M1
Sun Dec 31$-5.60$9.9M1
Mon Dec 31$-5.04$27.8M1